EUVIMEDEUVIMED entdecken
Open Access

Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy

Ece Duygu Gulsen, Rashad Ismayilov, Aydan Farzaliyeva, Mehmet Nezir Ramazanoglu, Arzu Oguz, Dalokay Kilic, Zafer Akcali, Ozden Altundag

In Vivo · 2026

DOI: 10.21873/invivo.14216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Ece Duygu Gulsen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Baskent University Faculty of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Neoadjuvant Therapy, Lung Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungNeoadjuvant TherapyLung NeoplasmsHumansMaleFemaleAgedMiddle AgedRetrospective StudiesPrognosisNeoplasm StagingTreatment OutcomeAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsAdultCombined Modality Therapy

Stichwörter der Autor:innen

Non-small-cell lung cancerneoadjuvant therapysurgical resection

Autor:innen und Institutionen

  • Department of Internal Medicine, Baskent University Faculty of Medicine, Ankara, Türkiye.
  • Department of Medical Oncology, Baskent University Faculty of Medicine, Ankara, Türkiye; rismayilov@baskent.edu.tr.
  • Department of Medical Oncology, Baskent University Faculty of Medicine, Ankara, Türkiye.
  • Department of Thoracic Surgery, Baskent University Faculty of Medicine, Ankara, Türkiye.

Zitieren

APA

Gulsen, E. D., Ismayilov, R., Farzaliyeva, A., Ramazanoglu, M. N., Oguz, A., Kilic, D., Akcali, Z., & Altundag, O. (2026). Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy. In Vivo. https://doi.org/10.21873/invivo.14216

Vancouver

Gulsen ED, Ismayilov R, Farzaliyeva A, Ramazanoglu MN, Oguz A, Kilic D, et al. Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy. In Vivo. 2026. doi:10.21873/invivo.14216

BibTeX
@article{Gulsen2026,
  author = {Gulsen, Ece Duygu and Ismayilov, Rashad and Farzaliyeva, Aydan and Ramazanoglu, Mehmet Nezir and Oguz, Arzu and Kilic, Dalokay and Akcali, Zafer and Altundag, Ozden},
  title = {Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy},
  journal = {In Vivo},
  year = {2026},
  doi = {10.21873/invivo.14216}
}
Kostenlos starten →